Positive Outlook for Carl Zeiss Meditec

20-Jul-2009 - Germany

Carl Zeiss Meditec AG is to continue the path of focus and growth initiated a year ago with Dr. Michael Kaschke (52) as President and CEO. Dr. Kaschke has resigned his suspended membership of the Supervisory Board.

"The entire Supervisory Board is impressed by the results achieved. With a targeted strategic direction, it has proved possible under Dr. Kaschke's leadership to keep the company on a path of success and growth even in these difficult economic times. For that reason, we will continue to put our trust in continuity," explained Dr. Markus Guthoff, Chairman of the Supervisory Board of Carl Zeiss Meditec AG.

"With a targeted focus on innovation, customer orientation and growth markets, we are posting pleasing results even in the context of the current economic situation. We will continue to invest in future-oriented topics. We can confirm our statement that Carl Zeiss Meditec will continue to grow while keeping the profitability stable and increasing it in the medium term. Compared to last year, we anticipate revenue growth of at least 5 percent in this current adverse year," concluded Dr. Michael Kaschke, President and CEO of Carl Zeiss Meditec AG.

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances